ASX:AFP (New Zealand)  
AFT Pharmaceuticals Ltd logo

AFT Pharmaceuticals Ltd

A$ 3.19 (+0.95%) Aug 17
P/E:
18.87
P/B:
6.61
Market Cap:
A$ 339.75M ($ 235.14M)
Enterprise V:
A$ 369.26M ($ 255.56M)
Volume:
1.24K
Avg Vol (2M):
6.43K
Also Trade In:
Volume:
1.24K
Market Cap A$:
339.75M
Market Cap $:
235.14M
PE Ratio:
18.87
Avg Vol (2-Month):
6.43K
Enterprise Value A$:
369.26M
Enterprise Value $:
255.56M
PB Ratio:
6.61
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

AFT Pharmaceuticals Ltd
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
Description
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Coco-scalp, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.
Name Current Vs Industry Vs History
Cash-To-Debt 0.2
Equity-to-Asset 0.47
Debt-to-Equity 0.71
Debt-to-EBITDA 1.83
Interest Coverage 7.66
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.35
Distress
Grey
Safe
Beneish M-Score -2.24
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.98
9-Day RSI 40.15
14-Day RSI 41.7
6-1 Month Momentum % -16.88
12-1 Month Momentum % -23.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.67
Quick Ratio 1.52
Cash Ratio 0.27
Days Inventory 179.79
Days Sales Outstanding 95.05
Days Payable 76.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.5

Financials

ASX:AFP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 122.765
EPS (TTM) (A$) 0.179
Beta -0.7
Volatility % 26.18
14-Day RSI 41.7
14-Day ATR (A$) 0.063552
20-Day SMA (A$) 3.3595
12-1 Month Momentum % -23.17
52-Week Range (A$) 2.91 - 4.8
Shares Outstanding (Mil) 104.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AFT Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data